U.S. Transportation Stock News

In its FY25 results released earlier this year, International General Insurance Holdings reported US$127.20 million in net income and solid book value growth, even as the wider industry faced softer pricing and higher catastrophe losses. An important angle for investors is IGI’s exposure to a hardening Middle East specialty market, where conflict-related losses are driving substantial rate increases in political violence and marine lines. With recent returns and rising rates in Middle...

Over the last 7 days, the United States market has remained flat, yet it has risen by 20% over the past year with earnings projected to grow by 18% annually in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued and have insider buying can offer intriguing opportunities for investors looking to capitalize on future growth prospects.

In the last week, the United States market has stayed flat, yet over the past 12 months, it has experienced a notable rise of 20%, with earnings forecasted to grow by 18% annually. In this context, identifying stocks that may be undervalued can provide opportunities for investors seeking to capitalize on potential growth while considering current market conditions.

The United States market has remained flat over the last week but has seen a notable 20% rise over the past 12 months, with earnings forecasted to grow by 18% annually. In this environment, growth companies with high insider ownership can be particularly attractive as they often align management's interests with shareholders and may capitalize on expanding revenue opportunities.

Over the last 7 days, the market has remained flat, while over the past 12 months, it has risen by 20%, with earnings forecast to grow by 18% annually. Investing in penny stocks—though a somewhat outdated term—can still open doors to growth opportunities, particularly in smaller or newer companies. These stocks can offer significant returns when backed by strong financial health; we'll explore several examples that combine balance sheet strength with potential for outsized gains.

The United States market remained flat over the last week but has experienced a 20% rise over the past 12 months, with earnings expected to grow by 18% annually in the coming years. In such an environment, selecting dividend stocks that offer consistent payouts and potential for growth can be an effective strategy to enhance your portfolio's stability and income.

BGC Group, Inc. was recently removed from the Russell 2000 Dynamic Index, a change that typically prompts portfolio rebalancing by index-tracking investors. This index exit highlights how benchmark membership can influence trading flows and visibility for a mid-cap financial services firm like BGC Group. Next, we’ll examine how BGC Group’s removal from the Russell 2000 Dynamic Index shapes its investment narrative and perceived market positioning. Uncover the next big thing with 20 elite...

DocuSign (DOCU) is back in focus after unveiling new AI powered agreement tools at its Momentum London conference, including the Iris AI engine and customizable agents designed to speed contract workflows for large customers. See our latest analysis for DocuSign. Recent AI announcements and index inclusions appear to have lifted sentiment in the very short term, with a 1 day share price return of 2.47% and 7 day share price return of 4.13%. However, the year to date share price return is down...

With the business potentially at an important milestone, we thought we'd take a closer look at Arq, Inc.'s ( NASDAQ:ARQ...

Solstice to acquire Element Solutions in cash and stock deal Element Solutions (ESI) is in the spotlight after Solstice Advanced Materials agreed to acquire the company in a cash and stock transaction valued at about $14.5b, including assumed net debt. Under the deal announced on July 6, 2026, Element Solutions shareholders are set to receive $10.00 in cash plus 0.5 Solstice shares for each Element share. This implies consideration of roughly $50.10 per share and a 15% premium to the July 2...

Kymera Therapeutics (KYMR) has finished enrolling patients earlier than planned in its global BROADEN2 Phase 2b trial of KT-621 for moderate to severe atopic dermatitis. As a result, the expected timeline for topline data has been moved forward. See our latest analysis for Kymera Therapeutics. The earlier KT-621 enrollment completion comes after a period of strong share price momentum for Kymera Therapeutics, with a 30 day share price return of 54.81% and a 1 year total shareholder return of...

Recent analyst actions on Full Truck Alliance (YMM), including an upgrade from JPMorgan and new coverage from Nomura, have refocused attention on the company’s digital freight platform, as well as its order growth and AI plans. See our latest analysis for Full Truck Alliance. At a share price of $8.67, Full Truck Alliance has seen a 7-day share price return of 7.30% and a 90-day share price return of 5.86%. However, the year-to-date share price return is down 22.93%, and the 1-year total...

Edgewell Personal Care Company (NYSE: EPC) was recently added to the Russell 2000 Dynamic Index, marking its inclusion in a widely followed small-cap benchmark that often attracts index-linked investment flows. This index inclusion could broaden Edgewell’s shareholder base and increase liquidity, potentially raising the profile of its ongoing brand, e-commerce, and efficiency initiatives among institutional investors. We’ll now explore how Edgewell’s addition to the Russell 2000 Dynamic...

In recent weeks, Travel + Leisure Co. drew renewed attention as major brokerages upgraded their views, emphasizing its recurring fee-based income, asset-light model, and differentiation within the travel sector ahead of previously scheduled second-quarter 2026 results. Analysts and valuation models also suggest the company’s shares may trade at a discount to intrinsic value based on cash flow and earnings metrics. Goldman Sachs’ upgrade to a Buy rating underscored confidence in Travel +...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

With the business potentially at an important milestone, we thought we'd take a closer look at Caris Life Sciences...

The Federal Reserve’s move toward flexible average inflation targeting, paired with an outlook for near zero interest rates, pushes income focused investors to rethink where they look for yield and stability. Real estate related stocks that already offer established dividend profiles can react in different ways to this shift in monetary policy. Some may benefit from cheaper financing and stronger support for employment and spending, while others could see pressure if inflation eats into real...

Novanta (NOVT) has filed a shelf registration for up to 2,142,857 common shares, totaling about US$337.6 million. This filing gives the company flexibility to raise equity capital for future corporate uses. See our latest analysis for Novanta. At a share price of US$164.89, Novanta has seen a 48.36% year to date share price return and a 28.02% total shareholder return over one year. The recent 43.03% 90 day share price return suggests momentum has been building ahead of and around the shelf...

In late June 2026, Pacira BioSciences announced that UnitedHealthcare, the largest U.S. health insurer, will now provide separate reimbursement for EXPAREL across outpatient settings, allowing the non-opioid postsurgical pain medication to be reimbursed outside the surgical bundle for eligible members. This move lifts financial barriers for roughly 40 million UnitedHealthcare members and contributes to about 150 million covered lives nationwide having access to separate reimbursement for...

AtriCure, Inc. was recently added to both the Russell 2000 Defensive Index and the Russell 2000 Growth-Defensive Index, while several senior executives increased their holdings through routine purchases under the company’s 2018 Employee Stock Purchase Plan at an effective price of US$23.78 per share. This index inclusion could broaden AtriCure’s shareholder base via benchmark-tracking funds, potentially influencing liquidity and investor perception alongside the insider participation in...

Index removals put Seaboard in focus Seaboard (SEB) has been removed from both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index. This change can prompt index-tracking funds to adjust positions and reassess exposure. See our latest analysis for Seaboard. Following its index removals, Seaboard’s share price has fallen 18.43% over the past 30 days and 23.19% over the past 90 days. The 1-year total shareholder return is 47.42%, indicating longer term holders have still...

In early July 2026, DXC Technology announced the general availability of DXC Private Cloud+, a Dell-powered hybrid private cloud designed to deliver public cloud–style flexibility, AI-ready infrastructure, and strict controls for sensitive and regulated workloads across sectors such as financial services, healthcare, government, and manufacturing. This launch, alongside DXC’s recent shift into the Russell 2000 family of indexes and new AI and autonomous logistics partnerships, highlights the...

The U.S. Industrial Exporters screener focuses on companies that sit right where trade policy meets real-world revenue. With a new U.S.-EU agreement, questions around USMCA, and ongoing U.S.-China tensions, these exporters face both fresh openings and added friction in key markets. For investors, that mix of risk and potential reward can make careful stock selection more important than ever. This article walks through 3 stocks from the screener that appear positively exposed to the latest...

Worthington Steel, Inc. recently reported fourth-quarter 2026 results showing sales of US$929.2 million but a net loss of US$48.7 million, driven largely by US$94.5 million of goodwill and long-lived asset impairment charges. Around the same time, the company refinanced its asset-based revolving credit facility with a new agreement of up to US$550.0 million and affirmed a US$0.16 quarterly dividend, signaling an effort to balance balance-sheet flexibility with continued cash returns to...